首页> 美国卫生研究院文献>BioMed Research International >Novel Treponema pallidum Recombinant Antigens for Syphilis Diagnostics: Current Status and Future Prospects
【2h】

Novel Treponema pallidum Recombinant Antigens for Syphilis Diagnostics: Current Status and Future Prospects

机译:用于梅毒诊断的新型梅毒螺旋体重组抗原:现状和未来展望

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The recombinant protein technology considerably promoted the development of rapid and accurate treponema-specific laboratory diagnostics of syphilis infection. For the last ten years, the immunodominant recombinant inner membrane lipoproteins are proved to be sensitive and specific antigens for syphilis screening. However, the development of an enlarged T. pallidum antigen panel for diagnostics of early and late syphilis and differentiation of syphilis stages or cured syphilis remains as actual goal of multidisciplinary expertise. Current review revealed novel recombinant antigens: surface-exposed proteins, adhesins, and periplasmic and flagellar proteins, which are promising candidates for the improved syphilis serological diagnostics. The opportunities and limitations of diagnostic usage of these antigens are discussed and the criteria for selection of optimal antigens panel summarized.
机译:重组蛋白技术极大地促进了梅毒感染的快速,准确的梅毒螺旋体特异性实验室诊断的发展。在过去的十年中,免疫优势的重组内膜脂蛋白被证明是用于梅毒筛查的敏感和特异性抗原。然而,发展用于诊断早期和晚期梅毒以及区分梅毒阶段或治愈梅毒的扩大的梅毒螺旋体抗原组仍然是多学科专业知识的实际目标。当前的评论揭示了新型重组抗原:表面暴露的蛋白质,粘附素以及周质和鞭毛蛋白质,它们有望成为改善梅毒血清学诊断的候选药物。讨论了这些抗原的诊断用途的机会和局限性,并总结了选择最佳抗原的标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号